Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 35.46% is in line with its 5-year average of 36.01%, around the middle of its 5-year range (31.18%–41.06%).
As of the fiscal period ended Wednesday, December 31, 2025. 7.32% below its 12-month average of 38.26%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
35.46%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
38.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
37.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
36.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
31.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
27.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
25.01%
CURRENT VS TTM AVG
-7.32%
CURRENT VS 3Y AVG
-5.47%
CURRENT VS 5Y AVG
-1.53%
CURRENT VS 10Y AVG
+12.35%
CURRENT VS 15Y AVG
+26.77%
CURRENT VS 20Y AVG
+41.78%
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+315.71%
vs the sector median at left
Mettler-Toledo International Inc.
Market Cap
$26.82B
Return on Invested Capital (ROIC)
35.46%
TTM Avg
38.26%
3Y Avg
37.51%
5Y Avg
36.01%
Market Cap
$27.56B
Return on Invested Capital (ROIC)
8.84%
TTM Avg
8.56%
3Y Avg
8.37%
5Y Avg
9.38%
Market Cap
$27.61B
Return on Invested Capital (ROIC)
16.61%
TTM Avg
13.40%
3Y Avg
11.07%
5Y Avg
9.62%
Market Cap
$28.33B
Return on Invested Capital (ROIC)
19.56%
TTM Avg
18.66%
3Y Avg
17.73%
5Y Avg
16.77%
Market Cap
$25.15B
Return on Invested Capital (ROIC)
8.43%
TTM Avg
7.70%
3Y Avg
8.24%
5Y Avg
10.04%
Market Cap
$24.42B
Return on Invested Capital (ROIC)
17.57%
TTM Avg
18.00%
3Y Avg
20.73%
5Y Avg
22.79%
Market Cap
$24.34B
Return on Invested Capital (ROIC)
7.39%
TTM Avg
6.30%
3Y Avg
5.64%
5Y Avg
7.56%
Market Cap
$29.85B
Return on Invested Capital (ROIC)
6.62%
TTM Avg
7.71%
3Y Avg
8.64%
5Y Avg
10.90%
Market Cap
$23.51B
Return on Invested Capital (ROIC)
20.58%
TTM Avg
10.42%
3Y Avg
9.36%
5Y Avg
7.13%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mettler-Toledo International Inc. (MTD) | $26.82B | 35.46% | 38.26% | 37.51% | 36.01% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $27.56B | 8.84% | 8.56% | 8.37% | 9.38% |
| DexCom, Inc. (DXCM)vs › | $27.61B | 16.61% | 13.40% | 11.07% | 9.62% |
| ResMed Inc. (RMD)vs › | $28.33B | 19.56% | 18.66% | 17.73% | 16.77% |
| Quest Diagnostics Incorporated (DGX)vs › | $25.15B | 8.43% | 7.70% | 8.24% | 10.04% |
| Waters Corporation (WAT)vs › | $24.42B | 17.57% | 18.00% | 20.73% | 22.79% |
| Labcorp Holdings Inc. (LH)vs › | $24.34B | 7.39% | 6.30% | 5.64% | 7.56% |
| Biogen Inc. (BIIB)vs › | $29.85B | 6.62% | 7.71% | 8.64% | 10.90% |
| Incyte Corporation (INCY)vs › | $23.51B | 20.58% | 10.42% | 9.36% | 7.13% |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.10B | 13.62% | 14.65% | 16.90% | 17.70% |
ROIC
35.5%
ROE
-3677.4%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 35.46% |
| 2024-12-31 | 41.06% |
| 2023-12-31 | 36.51% |
| 2022-12-31 | 37.01% |
| 2021-12-31 | 34.85% |
| 2020-12-31 | 31.18% |
| 2019-12-31 | 28.69% |
| 2018-12-31 | 27.77% |
| 2017-12-31 | 21.24% |
| 2016-12-31 | 25.77% |
| 2015-12-31 | 27.63% |
| 2014-12-31 | 25.06% |
| 2013-12-31 | 21.32% |
| 2012-12-31 | 21.43% |
| 2011-12-31 | 18.12% |
| 2010-12-31 | 14.45% |
| 2009-12-31 | 16.52% |
| 2008-12-31 | 18.29% |
| 2007-12-31 | 15.56% |
| 2006-12-31 | 17.27% |
| 2005-12-31 | 10.04% |
| 2004-12-31 | 10.28% |
| 2003-12-31 | 10.11% |
| 2002-12-31 | 14.37% |
| 2001-12-31 | 8.10% |
| 2000-12-31 | 14.39% |
| 1999-12-31 | 12.78% |
| 1998-12-31 | 10.45% |
| 1997-12-31 | 13.04% |
